PMC:6141714 / 37178-37406 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/6141714","sourcedb":"PMC","sourceid":"6141714","source_url":"https://www.ncbi.nlm.nih.gov/pmc/6141714","text":"(49) GVHD Bone marrow MSCs at first or second passage Humans ↑Survival rates↑Infection-related death Effectiveness MSCs at first or second passage \u003e effectiveness MSCs at third or fourth passage ↓IL-2 receptor in the serum","divisions":[{"label":"td","span":{"begin":0,"end":4}},{"label":"td","span":{"begin":6,"end":10}},{"label":"td","span":{"begin":12,"end":23}},{"label":"td","span":{"begin":25,"end":56}},{"label":"td","span":{"begin":58,"end":64}},{"label":"td","span":{"begin":66,"end":199}}],"tracks":[{"project":"MyTest","denotations":[{"id":"30254638-21820393-35421133","span":{"begin":1,"end":3},"obj":"21820393"}],"namespaces":[{"prefix":"_base","uri":"https://www.uniprot.org/uniprot/testbase"},{"prefix":"UniProtKB","uri":"https://www.uniprot.org/uniprot/"},{"prefix":"uniprot","uri":"https://www.uniprot.org/uniprotkb/"}],"attributes":[{"subj":"30254638-21820393-35421133","pred":"source","obj":"MyTest"}]},{"project":"2_test","denotations":[{"id":"30254638-21820393-35421133","span":{"begin":1,"end":3},"obj":"21820393"}],"attributes":[{"subj":"30254638-21820393-35421133","pred":"source","obj":"2_test"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"MyTest","color":"#dd93ec","default":true},{"id":"2_test","color":"#93ecc3"}]}]}}